openPR Logo
Press release

Bioengineered Protein Drugs Market worth $653.35 billion by 2030, growing at a CAGR of 7.65% - Exclusive Report by 360iResearch

12-04-2023 07:07 AM CET | Health & Medicine

Press release from: 360iResearch

Bioengineered Protein Drugs Market | 360iResearch

Bioengineered Protein Drugs Market | 360iResearch

The "Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

The Global Bioengineered Protein Drugs Market to grow from USD 362.12 billion in 2022 to USD 653.35 billion by 2030, at a CAGR of 7.65%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/bioengineered-protein-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=sample

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Bioengineered Protein Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Bioengineered Protein Drugs Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Bioengineered Protein Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ambrx, Inc., AMGEN INC., Aravive, Inc., Astrazeneca PLC, Baxter Healthcare, Bayer Pharmaceuticals, BRISTOL-MYERS SQUIBB, CSL LTD., F. HOFFMANN-LA ROCHE AG, GLAXOSMITHKLINE PLC, GRIFOLS S.A., Hoffman-la-Roche, MERCK & CO., INC., NOVARTIS AG, NOVO NORDISK A/S, PFIZER INC., Polaris Group, REGENERON PHARMACEUTICALS INC., SANOFI, and TAKEDA PHARMACEUTICAL CO., LTD..

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/bioengineered-protein-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Market Segmentation & Coverage:

This research report categorizes the Bioengineered Protein Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Type, market is studied across Monoclonal Antibodies, Therapeutic Proteins, and Vaccines. The Vaccines is projected to witness significant market share during forecast period.

Based on Disease, market is studied across Arthritis, Autoimmune Disorders, Blood Disorders, Cancer, Congenital Diseases, Heart Diseases, Infectious Diseases, Neurodegenerative Diseases, Respiratory Diseases, and Skin Diseases. The Respiratory Diseases is projected to witness significant market share during forecast period.

Based on End-User, market is studied across CROs, Pharmaceutical and Biotechnology Companies, and Research institutes. The Research institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Bioengineered Protein Drugs Market, by Drug Type
7. Bioengineered Protein Drugs Market, by Disease
8. Bioengineered Protein Drugs Market, by End-User
9. Americas Bioengineered Protein Drugs Market
10. Asia-Pacific Bioengineered Protein Drugs Market
11. Europe, Middle East & Africa Bioengineered Protein Drugs Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Bioengineered Protein Drugs Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Bioengineered Protein Drugs Market?
3. What is the competitive strategic window for opportunities in the Bioengineered Protein Drugs Market?
4. What are the technology trends and regulatory frameworks in the Bioengineered Protein Drugs Market?
5. What is the market share of the leading vendors in the Bioengineered Protein Drugs Market?
6. What modes and strategic moves are considered suitable for entering the Bioengineered Protein Drugs Market?

Read More @ https://www.360iresearch.com/library/intelligence/bioengineered-protein-drugs?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales"@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioengineered Protein Drugs Market worth $653.35 billion by 2030, growing at a CAGR of 7.65% - Exclusive Report by 360iResearch here

News-ID: 3313506 • Views:

More Releases from 360iResearch

Wearable Blood Pressure Monitor Market worth $7.07 billion by 2030, growing at a CAGR of 16.19% - Exclusive Report by 360iResearch
Wearable Blood Pressure Monitor Market worth $7.07 billion by 2030, growing at a …
The "Wearable Blood Pressure Monitor Market by Measurement (Arterial Tonometry, Oscillometric Method, Pulse Transit Time Method), Use (Arm, Wrist), Component, Indication, Distribution Channel, Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Wearable Blood Pressure Monitor Market to grow from USD 2.47 billion in 2023 to USD 7.07 billion by 2030, at a CAGR of 16.19%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/wearable-blood-pressure-monitor?utm_source=openpr&utm_medium=referral&utm_campaign=sample A wearable blood pressure monitor
Mobile Mapping Market worth $84.17 billion by 2030, growing at a CAGR of 15.75% - Exclusive Report by 360iResearch
Mobile Mapping Market worth $84.17 billion by 2030, growing at a CAGR of 15.75% …
The "Mobile Mapping Market by Product (3D Mapping, Indoor Mapping, Location-Based Services), Function (Aerial Mobile Mapping, Emergency Response Planning, Facility Management), End User, Industry - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Mobile Mapping Market to grow from USD 30.21 billion in 2023 to USD 84.17 billion by 2030, at a CAGR of 15.75%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/mobile-mapping?utm_source=openpr&utm_medium=referral&utm_campaign=sample Mobile mapping is the process of gathering
A2P & P2A Messaging Market worth $116.33 billion by 2030, growing at a CAGR of 7.14% - Exclusive Report by 360iResearch
A2P & P2A Messaging Market worth $116.33 billion by 2030, growing at a CAGR of 7 …
The "A2P & P2A Messaging Market by Type (A2P, P2A), Traffic (Multi-Country, National), Messaging Platform, Industry, Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global A2P & P2A Messaging Market to grow from USD 71.77 billion in 2023 to USD 116.33 billion by 2030, at a CAGR of 7.14%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/a2p-p2a-messaging?utm_source=openpr&utm_medium=referral&utm_campaign=sample A2P messaging, or Application-to-Person messaging, directs the transmission of messages from an
Tissue Diagnostics Market worth $14.02 billion by 2030, growing at a CAGR of 7.76% - Exclusive Report by 360iResearch
Tissue Diagnostics Market worth $14.02 billion by 2030, growing at a CAGR of 7.7 …
The "Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Tissue Diagnostics Market to grow from USD 8.30 billion in 2023 to USD 14.02 billion by 2030, at a CAGR of 7.76%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/tissue-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=sample Tissue diagnostics is a medical field that involves examining and analyzing

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug